Form 11 & Form 14 — In-House R&D Deduction Documentation Explained Line by Line

The in-house research and development deduction under section 45(2) of the Income-tax Act, 2025 is one of the most significant tax incentives for companies engaged in scientific research. The approval process requires meticulous documentation through specific forms prescribed by the Income Tax Rules, 2026. Understanding Form 11 (application for approval) and Form 14 (order of approval) is essential for companies seeking to claim this deduction, particularly in the aerospace, defence, pharmaceutical, and biotechnology sectors.

Overview of Section 45(2)

Statutory Provision

Section 45(2) provides a deduction for expenditure on scientific research incurred by a company engaged in:

• Bio-technology; or
• Manufacture or production of any article or thing (not being specified in Schedule XIII)

The deduction is available for expenditure on in-house research and development facility as approved by the prescribed authority.

Prescribed Authority

The Secretary, Department of Scientific and Industrial Research (DSIR), Government of India, is the prescribed authority for section 45(2).

Key Conditions

• The company must be engaged in eligible business
• The facility must be an in-house R&D facility
• The facility must be approved by the prescribed authority
• The company must enter into an agreement with the prescribed authority for co-operation in research and development
• The facility must not relate to market research, sales promotion, quality control, testing, commercial production, style changes, routine data collection or activities of a similar nature

Form 11 — Application for Approval

Purpose

Form 11 is the application form for entering into an agreement with the prescribed authority for co-operation in research and development facility under section 45(2). It is the first step in the approval process.

Filing Details

To Whom

• Secretary, Department of Scientific and Industrial Research (DSIR), Government of India

Timing

• At any time during the financial year immediately preceding the tax year from which approval is sought
• In case of approval from the tax year in which the applicant is incorporated, the application may be made during that tax year

Mode

• Electronic filing as specified by the Principal Director General of Income-tax (Systems)

Line-by-Line Explanation

Part I: Basic Information

1. Name of the Company

   • Full legal name as per Certificate of Incorporation
   • Should match with PAN and other statutory documents

2. Registered Office Address

   • Complete address with PIN code
   • Should match with ROC records

3. Corporate Identification Number (CIN)

   • As allotted by the Registrar of Companies
   • 21-character alphanumeric code

4. Permanent Account Number (PAN)

   • As allotted by the Income Tax Department
   • Must be valid and active

5. Date of Incorporation

   • As per Certificate of Incorporation
   • Determines eligibility for first-year approval

6. Date of Commencement of Business

   • As per the Certificate of Commencement of Business
   • For companies incorporated after 1st April, 2026, the date of incorporation may be treated as the date of commencement

7. Business Activity

   • Brief description of the business
   • Should indicate engagement in bio-technology or manufacture/production of articles/things (not specified in Schedule XIII)

8. Nature of Business

   • Manufacturing, bio-technology, or both
   • Should be consistent with the objects clause in the Memorandum of Association

Part II: Details of In-House R&D Facility

9. Location of R&D Facility

   • Complete address with PIN code
   • Should be in India

10. Date of Establishment of R&D Facility

    • Date when the facility was set up
    • For existing facilities, the date of establishment should be provided

11. Area of R&D Facility

    • Total floor area in square metres
    • Break-up into laboratory, testing, administrative, etc.

12. Description of R&D Facility

    • Detailed description of the infrastructure, equipment, and personnel
    • Should indicate the scientific nature of the facility

13. Research Areas

    • Specific research areas and programmes
    • Should be related to the business of the company

14. Details of Equipment and Machinery

    • List of major equipment and machinery
    • Description, quantity, cost, and year of acquisition

15. Details of Personnel

    • Number of personnel by category (scientists, engineers, technicians, support staff)
    • Qualifications and experience

16. Annual R&D Expenditure

    • Previous three years' expenditure (capital and revenue)
    • Current year's budgeted expenditure
    • Future projections

17. Proposed R&D Programmes

    • Detailed description of proposed R&D programmes
    • Objectives, timelines, and expected outcomes

18. Expected Benefits

    • Commercial, technological, and strategic benefits
    • Contribution to indigenisation, import substitution, etc.

Part III: Declaration and Undertaking

19. Declaration

    • That the company is engaged in eligible business
    • That the R&D facility is for scientific research
    • That the facility is not used for prohibited activities (market research, sales promotion, quality control, testing, commercial production, style changes, routine data collection)

20. Undertaking

    • To maintain separate books of account for the R&D facility
    • To get the accounts audited annually
    • To furnish audit report within the prescribed time
    • To utilise the assets only for the approved purpose
    • Not to dispose of assets without the approval of the prescribed authority

21. List of Documents

    • Memorandum of Association and Articles of Association
    • Certificate of Incorporation
    • Certificate of Commencement of Business
    • PAN card copy
    • Audited financial statements for the last three years
    • Details of R&D facility
    • Projected R&D expenditure
    • Organisational structure
    • Any other relevant documents

Part IV: Verification

22. Signature and Date

    • To be signed by the person authorised to verify the return of income (Managing Director, Director, etc.)
    • Date of signing

23. Designation

    • Designation of the signatory
    • Should be consistent with the company's records

Key Points to Note

• The application must be complete in all respects
• Incomplete applications may be rejected or delayed
• The prescribed authority may call for additional information
• The application should be filed well in advance of the due date

Form 14 — Order of Approval

Purpose

Form 14 is the order of approval issued by the prescribed authority under section 45(2). It is the formal approval of the in-house R&D facility.

Filing Details

Issued By

• Secretary, Department of Scientific and Industrial Research (DSIR), Government of India

Timing

• Within four months from the end of the month in which the application is received

Copy To

• The company
• Chief Commissioner of Income-tax having jurisdiction over the company

Line-by-Line Explanation

Part I: Basic Information

1. Order Number

   • Unique identification number of the order
   • Should be referenced in all future correspondence

2. Date of Order

   • Date on which the order is issued
   • Determines the effective date of approval

3. Name of the Company

   • Full legal name of the applicant company
   • Should match with the application

4. PAN of the Company

   • Permanent Account Number of the company
   • Should match with the application

Part II: Approval Details

5. Date of Approval

   • Date from which the approval is effective
   • Usually the date of the order or a specified earlier date

6. Period of Approval

   • The period for which the approval is granted
   • Not exceeding five tax years

7. Approval of Facility

   • Specific description of the approved R&D facility
   • Location, area, and scope of the facility

8. Conditions Subject to Which Approval is Granted

   • List of conditions
   • Should be strictly complied with

Part III: Conditions

Typical conditions in Form 14 include:

9. Maintenance of Separate Books of Account

   • The company shall maintain separate books of account for the approved R&D facility
   • The books shall be maintained as per the Companies Act, 2013 and the Income Tax Act

10. Annual Audit

    • The accounts shall be audited annually by an accountant as defined in section 515(3)(b)
    • The audit report shall be in Form 13

11. Filing of Audit Report

    • The audit report shall be furnished to the Secretary, DSIR, on or before the due date specified in section 263(1)(c)
    • For each succeeding tax year

12. Attachment of Audited Accounts

    • The company shall attach a copy of the audited annual account with the return of income

13. Reflection in Financial Statements

    • The capital and revenue expenditure on the R&D facility shall be reflected in the schedules or notes to accounts in the audited financial statement

14. Utilisation of Assets

    • The assets acquired by the approved facility shall be utilised only for the approved purpose
    • The assets shall not be disposed of without the approval of the Secretary, DSIR

15. Reporting

    • The company shall submit periodic reports on the progress of R&D activities
    • As required by the Secretary, DSIR

16. Compliance

    • The company shall comply with all the conditions subject to which approval is granted
    • Failure to comply may result in withdrawal of approval

Part IV: Withdrawal of Approval

17. Grounds for Withdrawal

    • If the facility ceases to exist
    • If the activities are not genuine
    • If the conditions are not fulfilled

18. Procedure for Withdrawal

    • Reasonable opportunity of being heard shall be given to the company
    • Copy of order shall be communicated to the company, Assessing Officer, and Chief Commissioner

19. Effective Date of Withdrawal

    • Date on which withdrawal takes effect
    • Usually the date of the order

Part V: Signatures

20. Signature of Prescribed Authority
    • Signature of the Secretary, DSIR (or authorised officer)
    • Name, designation, and date

Compliance Requirements After Approval

Form 12

The prescribed authority shall furnish:

• Part A: Report on approval of in-house R&D facility (within 120 days of grant of approval)
• Part B: Report quantifying expenditure incurred (within 120 days of submission of audit report)

Form 13 (Audit Report)

The company shall furnish the audit report in Form 13:

• On or before the due date specified in section 263(1)(c)
• For each succeeding tax year

Annual Account

• The company shall maintain separate books of account for each approved facility
• The accounts shall be audited annually
• A copy of the audited annual account shall be attached with the return of income

Reporting

• The company shall submit periodic reports on the progress of R&D activities
• As required by the Secretary, DSIR

Practical Considerations

Timing of Application

• Apply well in advance of the tax year for which deduction is sought
• For existing facilities, apply as soon as possible
• Incomplete applications will be returned

Documentation

• Ensure all documents are up-to-date
• Maintain separate records for the R&D facility
• Keep copies of all correspondence

Compliance Monitoring

• Appoint a responsible person for compliance
• Monitor compliance with conditions
• File audit reports and returns within due dates

Expert Advisory

Given the complexity of the approval process and the importance of compliance, professional advisory is essential. Anuj Desai & Associates provides comprehensive services for Form 11 and Form 14, including:

• Application Preparation: Assistance with Form 11 preparation and filing
• Documentation: Compilation and review of supporting documents
• Compliance: Assistance with Form 13 and annual compliance
• Representation: Representation before the prescribed authority
• Dispute Resolution: Assistance with withdrawal of approval and appeals

With deep expertise in R&D deduction provisions, Anuj Desai & Associates ensures that your in-house R&D facility receives the maximum tax benefits while maintaining full compliance.

---

Need expert assistance with Form 11 or Form 14 for your in-house R&D facility? Contact Anuj Desai & Associates today for comprehensive advisory, application, and compliance services. [Contact Us] to schedule a consultation.